Format

Send to

Choose Destination
See comment in PubMed Commons below
Am Fam Physician. 2003 Nov 1;68(9):1795-8.

Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.

Author information

  • 1Harrisburg Family Practice Residency, Harrisburg, Pennsylvania 17104, USA.

Abstract

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers have different pharmacologic mechanisms for blocking the effect of the renin-angiotensin-aldosterone system on the cardiovascular system. Pharmacologically, the combination of these drug classes completely blocks the deleterious effect of angiotensin in patients with heart failure. However, clinical trials have not shown a marked benefit from using this combination compared with using angiotensin-converting enzyme inhibitors alone. Patients who take combination therapy do not live longer, although they are less likely to be hospitalized for worsening symptoms. Most patients who take combination therapy will not experience marked improvement in symptoms or quality of life.

PMID:
14620599
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Academy of Family Physicians
    Loading ...
    Write to the Help Desk